Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
NASDAQ 4,148.34 21.37 0.52%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,445.30 40.31 0.28%
TOPIX 1,171.93 7.03 0.60%
HANG SENG 22,562.80 53.16 0.24%

Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference



Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare
Conference

CAMBRIDGE, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the 32^nd Annual J.P. Morgan Healthcare Conference on
Wednesday, January 15, 2014 at 11:00 a.m. Pacific Time at the Westin St.
Francis Hotel in San Francisco.  

The live and archived webcast of the company presentation can be accessed
under "Events and Presentations" in the Idenix Investor Center at
www.idenix.com. Please log in approximately 5-10 minutes before the event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conference.

ABOUT IDENIX

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical Company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with hepatitis C infection. For further information
about Idenix, please refer to www.idenix.com.

CONTACT: Idenix Pharmaceuticals Contact:
         Teri Dahlman
         (617) 995-9807

Idenix Pharmaceuticals logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement